Safety of Hypericum extract in mildly to moderately depressed outpatients: A review based on data from three randomized, placebo-controlled trials

Journal of Affective Disorders

Volumn 82, Issue 2, 2004, Pages 303-307

  Trautmann Sponsel, R D ^a   Dienel, Angelika ^b  

^a Psychosomatische Klinik GmbH and Co   (Germany)

^b DR WILLMAR SCHWABE GMBH AND CO KG   (Germany)

Author keywords

Extract; Hypericum; Outpatients

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CITALOPRAM; FLUOXETINE; FLUVOXAMINE; HERBACEOUS AGENT; HYPERICUM EXTRACT; MIRTAZAPINE; PAROXETINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ABDOMINAL PAIN; AGITATION; AKATHISIA; ANORGASMIA; ANTICHOLINERGIC EFFECT; ANXIETY; BACKACHE; BRONCHITIS; CHILL; CONFIDENCE INTERVAL; CONSTIPATION; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIARRHEA; DIGESTIVE SYSTEM FUNCTION DISORDER; DIZZINESS; DROWSINESS; DRUG SAFETY; DRUG TOLERABILITY; DYSMENORRHEA; DYSPNEA; FAINTNESS; FATIGUE; FEVER; HEADACHE; HEART ARRHYTHMIA; HEART PALPITATION; HOSTILITY; HUMAN; HYPOTENSION; IMPOTENCE; INFLUENZA; INSOMNIA; MAJOR CLINICAL STUDY; MENSTRUATION DISORDER; MICTURITION DISORDER; NAUSEA; NERVOUSNESS; NOSE CONGESTION; ORTHOSTATIC HYPOTENSION; OUTPATIENT; PHARYNGITIS; PHARYNX DISEASE; PRIORITY JOURNAL; RASH; RESPIRATORY TRACT DISEASE; REVIEW; RISK ASSESSMENT; SEDATION; SEXUAL DYSFUNCTION; SOMNOLENCE; SYNCOPE; TACHYCARDIA; UPPER RESPIRATORY TRACT INFECTION; URINARY FREQUENCY; URINE RETENTION; VERTIGO; VOMITING; XEROSTOMIA;

EID: 5644262758     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2003.12.017     Document Type: Article

References (21)

1. Brockmöller J., Reum T., Bauer S., Kerb R., Hübner W.D., Roots I. Hypericin and pseudohypericin: pharmacokinetics and effects on photosensitivity in humans. Pharmacopsychiatry. 30:(Suppl. 2):1997;94-101
2. Dürr D., Steiger B., Kullak-Ublik G.A., Rentsch K.M., Steinert H.C., Meier P.J., Fattinger K. St. John's wort induces intestinal P-glycoprotein/MDRI and intestinal and hepatic CYP3A4. Clin. Pharmacol. Ther. 68:2000;598-604
3. Ernst E. Second thoughts about safety of St. John's wort. Lancet. 354:1999;2014-2016
4. Ernst E., Rand J.I., Barnes J., Stevinson C. Adverse effects profile of the herbal antidepressant St. John's wort (Hypericum perforatum L.). Eur. J. Clin. Pharmacol. 54:1998;589-594
5. Golsch S., Vocks E., Rakoski J., Brockow K., Ring J. Reversible erhöhung der photosensitivität im UV-B-bereich durch johanniskrautextrakt-präparate. Hautarzt. 48:1996;249-252
6. Hippius H. St. John's Wort (Hypericum perforatum) - a herbal antidepressant. Curr. Med. Res. Opin. 14:1998;171-184
7. Kalb R., Trautmann-Sponsel R.D., Kieser M. Efficacy and tolerability of Hypericum extract WS 5572 versus placebo in mildly to moderately depressed patients. A randomized double-blind multicenter clinical trial. Pharmacopsychiatry. 34:2001;96-103
8. Kim H.L., Streltzer J., Goebert D. St. John's wort for depression: a meta-analysis of well-defined clinical trials. J. Nerv. Ment. Dis. 187:1999;532-538
9. Laakmann G., Schüle C., Baghai T., Kieser M. St. John's wort in mild to moderate depression: the relevance of hyperforin for the clinical efficacy. Pharmacopsychiatry. 31:(Suppl. 1):1998;545-549
10. Lecrubier Y., Clerc G., Didi R., Kieser M. Efficacy of St. John's wort extract WS 5570 in major depression: a double-blind, placebo-controlled trial. Am. J. Psychiatry. 159:2002;1361-1366
11. Linde K., Ramirez G., Mulrow C.D., Pauls A., Weidenhammer W., Melchart D. St. John's wort for depression - an overview and meta-analysis of randomised clinical trials. Br. Med. J. 313:1996;253-258
12. Montgomery S.A. Safety of mirtazapine: a review. Int. Clin. Psychopharmacol. 10:(Suppl. 4):1995;37-45
13. Newcombe R.G. Interval estimation for the difference between independent proportions: comparison of eleven methods. Stat. Med. 17:1998;873-890
14. Preskorn S.H. Clinical Pharmacology of Selective Serotonin Reuptake Inhibitors. 1996;Professional Communications, Caddo, OK
15. Preskorn S.H. The adverse effect profiles of the selective serotonin reuptake inhibitors: relationship to in vitro pharmacology. J. Psychiatr. Pract. 6:2000;153-157
16. Rychlik R., Siedentop H., von den Driesch V., Kasper S. Johanniskrautextrakt WS 5572 bei leichten bis mittelschweren depressionen. Wirksamkeit und verträglichkeit von 600 und 1200 mg wirkstoff täglich. Fortschr. Med. 119:2001;119-128
17. Schulz V., Hänsel R., Tyler V. Rational Phytotherapy - A Physician's Guide to Herbal Medicine. 1998;Springer, Berlin
18. Stevinson C., Ernst E. Safety of Hypericum in patients with depression. A comparison with conventional antidepressants. CNS Drugs. 11:1999;125-137
19. Wheatley D. Hypericum extract. Potential in the treatment of depression. CNS Drugs. 9:1998;431-440
20. Woelk H., Burkard G., Grünwald J. Benefits and risks of the Hypericum extract LI 160: drug monitoring study with 3250 patients. J. Geriatr. Psychiatry Neurol. 7:(Suppl. 1):1994;S34-S38
21. Zuess J. The Natural Prozac Program: How to Use St. John's Wort, An Antidepressant Herb. 1997;Three Rivers Press, New York